Journal:PMC:1
From Proteopedia
(Difference between revisions)

Line 11: | Line 11: | ||
====Proposition #2. Steric hinderance of some centric portion of the piperidine ring explains antagonist properties of naloxone, naltrexone and alvimopam.==== | ====Proposition #2. Steric hinderance of some centric portion of the piperidine ring explains antagonist properties of naloxone, naltrexone and alvimopam.==== | ||
- | <scene name='Journal:PMC:1/Cv1/4'>These steric effects are caused by the OH and allyl side chains which block more than a peripheral portion of the piperidine ring</scene> in Naloxone. <scene name='Journal:PMC:1/Cv1/5'>Naltrexone with a bulkier side chain</scene> is more antagonistic than Naloxone. In humans, <scene name='Journal:PMC:1/Cv1/6'>Alvimopam is an antagonist and there is significant hindrance of the piperidine ring by the second aromatic ring</scene> <span style="color:yellow;background-color:black;font-weight:bold;">(in yellow)</span>. | + | <scene name='Journal:PMC:1/Cv1/4'>These steric effects are caused by the OH and allyl side chains which block more than a peripheral portion of the piperidine ring</scene> in Naloxone. <scene name='Journal:PMC:1/Cv1/5'>Naltrexone with a bulkier side chain</scene> is more antagonistic than Naloxone. In humans, <scene name='Journal:PMC:1/Cv1/6'>Alvimopam is an antagonist and there is significant hindrance of the piperidine ring by the second aromatic ring</scene> <span style="color:yellow;background-color:black;font-weight:bold;">(in yellow)</span>. |
+ | ====Proposition #3. Methadone has an active conformation which contains a virtual heterocyclic ring which explains its | ||
+ | analgesic activity and racemic properties==== | ||
+ | |||
+ | <scene name='Journal:PMC:1/Cv2/3'>Methadone has a unique structure compared to other opioids since it does not possess a heterocyclic ring.</scene> | ||
</StructureSection> | </StructureSection> | ||
<references/> | <references/> | ||
__NOEDITSECTION__ | __NOEDITSECTION__ |
Revision as of 08:53, 23 November 2011
|
- ↑ Joel S. Goldberg, Perspectives in Medicinal Chemistry 2010:4 1-10, Stereochemical Basis for a Unified Structure Activity Theory of Aromatic and Heterocyclic Rings in Selected Opioids and Opioid Peptides doi:http://dx.doi.org/10.4137/PMC.S3898
This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.